|
- Artesunate-induced hemolysis in severe complicated malaria – A . . .
Gómez-Junyent J , Ruiz-Panales P , Calvo-Cano A , Gascón J , Muñoz J Delayed haemolysis after artesunate therapy in a cohort of patients with severe imported malaria due to Plasmodium falciparum
- Published Reports of Delayed Hemolytic Anemia After Treatment with . . .
Clinicians treating patients for severe malaria with artesunate should monitor the patient for 4 weeks after treatment, assess for hemolysis if anemia is present, and report any episodes of delayed hemolysis to CDC
- Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated . . .
Delayed-onset anemia (herein referred to as postartesunate delayed-onset hemolysis [PADH] pattern of anemia) has been observed to occur 2–3 weeks after initiation of IV artesunate, after complete clearance of parasites, and to resolve during weeks 3–6 (7)
- Severe falciparum malaria treated with artesunate complicated by . . .
This report describes the first case of a patient from an unstable malaria transmission area presenting with delayed-onset haemolysis complicated by acute kidney injury following treatment of severe malaria with intravenous artesunate and follow-on oral artemether lumefantrine combination treatment
- Post-artesunate delayed hemolysis after treatment of malaria with . . .
Delayed hemolysis is an uncommon reaction to intravenous artesunate for the treatment of severe malaria We report a case of a patient who developed severe malaria after initial improper treatment, thus requiring IV artesunate therapy Delayed hemolytic anemia then occurred and was monitored for weeks after completion of treatment
- Post-treatment haemolysis is common following oral artemisinin . . .
Episodes of delayed haemolysis occur in up to 57 9% of patients with severe malaria treated with intravenous artesunate, mainly caused by ‘pitting’ of infected red blood cells in the spleen and the delayed loss of these once-infected RBCs (oiRBCs)
- MALARIA VS A THERAPEUTIC AGENT: CAUSE OF HEMOLYTIC ANEMIA? - CHEST
Post-Artesunate Delayed Hemolysis (PADH) occurs in approximately 20-25% of AS-treated patients It usually DISCUSSION: happens after parasite clearance and resolution of malaria-related symptoms AS induces pitting, a process in the spleen where dead parasites are expelled from infected erythrocytes
- Postartesunate delayed hemolysis is a predictable event related to the . . .
Delayed clearance of infected erythrocytes spared by pitting during AS treatment is an original mechanism of hemolytic anemia Our findings consolidate a disease framework for posttreatment anemia in malaria in which delayed hemolysis is a new entity
|
|
|